Page 11 - aruba-today-20220113
P. 11

A11
                                                                                                  business Thursday 13 January 2022
            Biogen tumbles after Medicare lays out Aduhelm coverage plan




            By TOM MURPHY                                                                                                       early-stage Alzheimer's and
            AP Health Writer                                                                                                    expect to complete the re-
            Shares   of   Biogen    slid                                                                                        search about four years af-
            Wednesday,  a  day  after                                                                                           ter the study begins.
            federal  regulators  slapped                                                                                        Aduhelm  has  been  hailed
            coverage limitations on the                                                                                         as  a  promising  treatment
            drugmaker's  new  Alzheim-                                                                                          by  some  researchers  be-
            er's disease treatment.                                                                                             cause  it  has  the  potential
            The  Centers  for  Medicare                                                                                         to  slow  the  fatal  Alzheim-
            and    Medicaid    Services                                                                                         er's.  No  drugs  on  the  mar-
            said Tuesday after markets                                                                                          ket currently do that.
            closed  that  patients  tak-                                                                                        But  concerns  about  the
            ing  Biogen's  Aduhelm  will                                                                                        cost   and   effectiveness
            have to also participate in                                                                                         have slowed the drug's de-
            clinical  trials  to  assess  the                                                                                   but.
            drug's  effectiveness  in  or-                                                                                      Biogen  CEO  Michel  Vou-
            der  for  Medicare  to  cover                                                                                       natsos  said  on  Monday
            the cost.                                                                                                           that the company now has
            That's an important caveat                                                                                          about 220 sites treating pa-
            because  Medicare  is  ex-                                                                                          tients with Aduhelm.
            pected  to  cover  most  of                                                                                         Biogen said in June, shortly
            the  patients  who  opt  for                                                                                        after  the  FDA  approval,
            Aduhelm, and the drug can                                                                                           that  about  900  sites  in  the
            cost  as  much  as  $28,000                                                                        Associated Press  U.S.  have  the  equipment
            annually,  not  counting  ex-  curities  USA  analyst  Salim  The U.S. Food and Drug Ad-  likely  to  benefit  patients.  and  expertise  to  immedi-
            penses for brain scans and  Syed. He had previously es-   ministration  had  approved  But  they've  asked  for  an-  ately begin giving the drug,
            other  care  patients  will  timated around $3.5 billion  Aduhelm  last  June  and  other study.                    which requires monthly IVs.
            need while taking it.        to $4 billion in peak annual  later  said  it  was  appropri-  Biogen  said  last  month  Shares   of   Cambridge,
            Biogen  had  cut  that  cost  sales for the drug.         ate  for  patients  with  mild  that  it  would  submit  final  Massachusetts-based  Bio-
            down  from  more  than  But he said Wednesday he  symptoms  or  early-stage  plans  for  that  study  to  the  gen Inc. fell more than 8%,
            $50,000 annually last month  now assumes less than $100  Alzheimer's.                  Food and Drug Administra-    or  nearly  $21,  to  $220.56
            after taking months of criti-  million. Medicare's national  Aduhelm   clears   brain  tion in March. It then plans  Wednesday  morning  while
            cism over the expense.       coverage     determination  plaque  thought  to  play  a  to  have  the  first  patient  broader indexes rose slight-
            The  initial  Medicare  cov-  will  become  final  by  April  role  in  Alzheimer's  disease,  screened  for  the  research  ly at the start of trading.
            erage  decision  will  sig-  11, following a public com-  and  regulators  made  their  by May.                      The stock price had soared
            nificantly  limit  access  to  ment  period  and  further  call  based  on  research  Researchers will aim to en-   past $400 after the FDA de-
            Aduhelm,  said  Mizuho  Se-  evaluation by the agency.    showing  the  drug  seemed  roll about 1,300 people with  cision in June.q


            Edmunds: Shopping for a car this year

            will not be the same


            By RONALD MONTOYA            five  ways  that  car  buying  ing  up  vehicles.  If  you  see
            Edmunds                      has changed, along with a  one you like, be prepared
            2021  was  an  unusual  year  few tips on how to manage  to move quickly because it
            for the automotive industry.  it.                         may not be there the next
            While  customer  demand  ONGOING VEHICLE SHORT-           time.
            for  new  cars  rebounded  AGE MEANS HIGHER PRICES        YOU'RE MORE LIKELY TO OR-    der  a  vehicle  is  to  use  an  research before your lease
            from the economic uncer-     Vehicles  that  make  their  DER YOUR NEXT CAR            automaker's  website  to  ends to find affordable op-
            tainty  of  2020,  automakers  way onto the lot are more  One  way  to  avoid  the  build  the  vehicle  configu-   tions,  said  Drury.  You  can
            found  themselves  unable  likely  to  be  in  more  ex-  markups  and  dealer  add-   ration  you  want  and  then  also  consider  buying  out
            to  meet  that  demand  be-  pensive  trims  and  either  ons is to order the vehicle.  send  that  information  to  your lease, as it will likely be
            cause  of  semiconductor  marked up in price or with  This  ensures  that  you  get  your preferred dealership.     a better deal since the sell-
            chip  shortages  and  supply  numerous  dealer-installed  exactly  the  color  and  op-  LEASING  WILL  BE  LESS  EN-  ing price for it was calculat-
            chain  problems.  So  what  accessories  that  achieve  tions  that  you  want,  pro-  TICING                       ed years before the market
            should  car  shoppers  ex-   the same effect. And if that  vided you're willing to wait  Edmunds   analysts   say  took a turn.
            pect for 2022? Much of the  wasn't enough to contend  roughly six to eight weeks.      that  leasing  is  becoming  USED  VEHICLES  MAY  NOT
            same, unfortunately.         with, you'll find that dealer-  The  basic  idea  is  that  or-  less  popular  for  a  couple  OFFER RELIEF
            "Competition  for  new  ve-  ships are much less likely to  dering  a  vehicle  saves  of  reasons.  As  inventories  Many  new-vehicle  shop-
            hicles  will  be  fierce  as  in-  come down on price since  the  dealership  on  lot  fees  remain  low  and  the  cars  pers  turned  to  the  used
            ventory shortages persist in  they  know  there  aren't  and  insurance  for  vehicles  that  are  in  stock  tend  to  market  for  a  better  selec-
            2022,"  said  Ivan  Drury,  Ed-  many  other  options  avail-  parked  on-  or  off-site,  and  be  more  loaded  with  op-  tion  or  respite  from  the
            munds'  senior  manager  of  able. It's a textbook case of  it can then pass the savings  tions, they're less likely to be  higher  new  car  prices.  But
            insights for Edmunds.        supply and demand.           on  to  the  consumer.  The  targeted  by  automakers'  this, in turn, caused its own
            Shoppers  today  must  con-  These  days,  paying  MSRP  "savings" these days is pay-  leasing  programs  because  shortage  and  record-high
            tend  with  a  limited  selec-  might actually be a "good  ing  MSRP  and  not  being  these   vehicles   typically  prices.  Edmunds  analysts
            tion,  dealership  markups,  deal," relatively speaking.   charged  for  dealer  add-  suffer  higher  depreciation  predict that in the coming
            little  to  no  discounts,  and  Tip:  We  recommend  cast-  ons  or  the  convenience  than their mid- to lower-lev-  year, the average used ve-
            a greater sense of urgency  ing  your  net  out  farther  to  of  having  a  vehicle  right  el trim counterparts.  hicle  price  will  surpass  the
            to move quickly on a deal.  increase  your  options.  Not  away.                       Tip: You might need to do  $30,000  mark  for  the  first
            With  this  in  mind,  here  are  every  dealership  is  mark-  Tip:  The  easiest  way  to  or-  some  extra  planning  and  time. q
   6   7   8   9   10   11   12   13   14   15   16